ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,893.62
      0.39%
      US Tech 100
      19,988.40
      0.63%
      Dow Jones
      43,389.60
      -0.13%
      Brent Oil
      73.275
      0.47%
      Bitcoin
      91,446.10
      0.99%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Precision BioSciences Inc (DTIL)

      7. Precision BioSciences Inc (DTIL) News

      Precision BioSciences Inc

      Precision BioSciences Inc (DTIL)

      NASDAQ
      7.26
      -0.36
      (-4.72%)
      Closed November 18 4:00PM
      Delayed by 15 minutes
      7.26
      0.00
      (0.00%)
      After Hours: 4:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      DTIL News

      Official News Only

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 05 2024
      DTIL (-4.72%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 05 2024
      DTIL (-4.72%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      November 05 2024
      DTIL (-4.72%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      November 04 2024
      DTIL (-4.72%)

      Form 144 - Report of proposed sale of securities
      Edgar (US Regulatory)
      November 04 2024
      DTIL (-4.72%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 04 2024
      DTIL (-4.72%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 04 2024
      DTIL (-4.72%)

      DTIL Discussion

      View Posts
      Monksdream Monksdream 2 months ago
      DTIL under $10
      👍️0
      Monksdream Monksdream 5 months ago
      DTIL under $10
      👍️0
      jondoeuk jondoeuk 5 months ago
      I think they did, but there are still a lot of vampires sucking away at the (limited) revenue.
      👍️0
      Monksdream Monksdream 7 months ago
      DTIL under $10
      👍️0
      NY1972 NY1972 7 months ago
      Why they hired a Chief People Officer instead of of trimming head count? another GNCA IMO
      👍️0
      jondoeuk jondoeuk 7 months ago
      Management can try and spin this as much as they want, but this is a failure https://www.businesswire.com/news/home/20240416117356/en/Precision-BioSciences-Announces-Return-of-Programs-and-Conclusion-of-Collaboration-with-Prevail-Therapeutics
      👍️0
      jondoeuk jondoeuk 7 months ago
      If one of the companies that are developing off-the-shelf succeed, I don't see why any insurer will pay the price tag of an autologous therapy (assuming similar data/success). On paper, it should be easier than oncology.
      👍️0
      Monksdream Monksdream 8 months ago
      DTIL 10Q due March 13
      👍️0
      jondoeuk jondoeuk 9 months ago
      That didn't take long! https://www.businesswire.com/news/home/20240301968620/en/Precision-BioSciences-Announces-40.0-Million-Offering-of-Common-Stock-and-Warrants

      Maybe things are going slower on the clinical front or no milestone payments are expected.
      👍️0
      rtrstock rtrstock 9 months ago
      What do you mean an offering?
      👍️0
      surf1944 surf1944 9 months ago
      Precision BioSciences, Inc. (DTIL) will effect a one-for-thirty (1-30) reverse split of its Common Stock. The reverse stock split will become effective on Wednesday, February 14, 2024. In conjunction with the reverse split, the CUSIP number will change to 74019P207

      The 1 for 30 R/S will make it easy is come out with an offering in the next week or so.
      👍️0
      rtrstock rtrstock 9 months ago
      1 for 30 not bad, but still will have to hold a long time to get my money back, if I ever do, averaged in at maybe 1.30, so uncertain what price will need to be after reverse split eventually to even break even. Wanting to hold long and make money eventually, but unsure if that's still possible.

      I have 5100 shares, so that will be cut to practically nothing, it'd have to go to nearly 50.00 a share for me to make my money back?

      Is this correct? Is basically everyone even the big investors like Lilly and Cargill losing big on this one?
      👍️0
      jondoeuk jondoeuk 9 months ago
      Now there will be one. The BOD approved a 1-for-30 R/S. It will become effective at 5:00 p.m. ET on Feb 13. The uncertainty has been eliminated.
      👍️0
      rtrstock rtrstock 10 months ago
      Guess I'll hold even if there is a R/S
      👍️0
      jondoeuk jondoeuk 10 months ago
      I thought they would, but it seems to me that they want to allow the clock to run before they set a R/S. Looking at the filing, it leaves the effective date to the BOD's discretion. It also gives the them the discretion to abandon it. The company has until the 22nd of April for the stock price to attain what is needed, thereby keeping its listing.
      👍️0
      NY1972 NY1972 10 months ago
      Side dish becomes the main course. High paid bio CEOs need another bait and switch.
      👍️0
      jondoeuk jondoeuk 10 months ago
      Autoimmune diseases are clearly the next frontier for CAR-T/NK cell therapies, with numerous biotech and (big) pharma companies in the space https://finance.yahoo.com/news/precision-biosciences-completes-license-deal-120000510.html
      👍️ 1
      81vette 81vette 10 months ago
      Res. Breakout,after hours could get fun
      👍️ 1
      81vette 81vette 10 months ago
      Accumulation at nhod
      👍️ 1
      81vette 81vette 10 months ago
      11th most newly watched ticker,do dd,others are
      👍️0
      81vette 81vette 10 months ago
      The 2.5m buy, should open some eyes
      👍️0
      81vette 81vette 10 months ago
      Death hour is over,mid day vol surge coming,this pennant has gotten pointy/pokey/stabby(technical terms lol)held strong with .4333 last low bounce,demand growing now,waiting for thru .44 to send it higher
      👍️0
      81vette 81vette 10 months ago
      DTIL astronomical potential=greed/hold,tutes own 27%,insiders 21%,100M cash(no offerings),eps this year up 60%/sales past 5years up 102%(tells me sales have started and that explains tutes,I expect they buy more now) 27%below the sma200(so it’s got at least that much run room) target price 2.62, 198 employees,bullish chart since Oct 30th,could be some bashers because it is optionable/shortable,institutional could send this flying up,relative buying vol up 148Xs today ,shares available to short is dropping but still 3.5M(was 4.3m) overall I like that I can put this in my portfolio for long(or until chart breaks) and not have to watch it like a nail biting pump and dump,I have too many of those already lol
      👍️0
      rtrstock rtrstock 12 months ago
      What indication of a RS is there? Or is it assumed?

      This looks like a good buy to me, am I wrong?
      👍️0
      NY1972 NY1972 12 months ago
      Plenty dead bios walking in this mkt. still handing out options like clock work.
      👍️0
      NY1972 NY1972 12 months ago
      This bio is walking dead. Failure to let go the PhDs and CARTs a few years ago costed hundreds millions. ARCUS will be bought by IECure after the cash dries up.
      👍️0
      jondoeuk jondoeuk 12 months ago
      Yes, but I think the R/S will happen.
      👍️0
      Sirpeter Sirpeter 12 months ago
      There's still time
      👍️0
      jondoeuk jondoeuk 12 months ago
      So, at 4:30pm the day before Thanksgiving, they announce a special meeting to vote on a R/S. It will take place on Thurs, Jan 18, '24, at 11:00 am, Eastern Time, at a ratio ranging from 1-for-10 and 1-for-30.
      👍️0
      Sirpeter Sirpeter 12 months ago
      Moving up nicely...looks good
      👍️0
      knrorrel knrorrel 1 year ago
      nice chart, bottom now and here, Now get the news out and let's see what happens, maybe we'll almost never see these low prices down here on the ground again.
      imho
      👍️0
      knrorrel knrorrel 1 year ago
      News Out, should running hard in good News
      imho
      👍️0
      knrorrel knrorrel 1 year ago
      a really nice $DTIL News https://ih.advfn.com/stock-market/NASDAQ/precision-biosciences-DTIL/stock-news/92484281/precision-biosciences-reports-third-quarter-2023-f


      👍️0
      rtrstock rtrstock 1 year ago
      Well on stock twits they are saying there is no filed reverse split and that they are expecting an extension to be filed, so I hope you are right. I'm uncertain what all is going on, but I like what this company is doing with it's aspirations in medicine, so staying with it. Just accumulated more, lowered my average cost.
      👍️0
      konshe konshe 1 year ago
      bottom rebound coming, time to buy.
      👍️ 1
      Monksdream Monksdream 1 year ago
      DTIL new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      DTIL new 52 week low
      👍️0
      Monksdream Monksdream 1 year ago
      DTIL new 52 wewek low
      👍️0
      NY1972 NY1972 1 year ago
      DTIL founders never worried about cash until the meltdown. They hired too many PhDs, built fancy expensive labs with lots of promises. They never tried to trim the expenses to make sure there will be cash left for clinical trials. High burn and lots of GT bios spell doom for this bio.
      👍️0
      jondoeuk jondoeuk 1 year ago
      I should have pointed out that companies are happening to develop small[er] nucleases. Here is one paper from Casebia Therapeutics, which is a joint venture between CRSP and BAYN https://www.nature.com/articles/s41467-021-24454-5

      Also, in 2020, researchers led by Dr. Liu created a new base editor that could perform C-to-T conversion of DNA in mitochondria. However, it had limitations, not only being restricted to that conversion, but mostly limited a certain motif. This means that it could correct only 10% of confirmed pathogenic mitochondrial point mutations https://www.nature.com/articles/s41587-022-01256-8

      Last year another novel base editor was created that could achieve A-to-G conversion. Being able to perform that could correct 43% of confirmed pathogenic mitochondrial point mutations https://www.cell.com/cell/fulltext/S0092-8674(22)00389-0

      However, I don't see either base editor entering the clinic for a number of years.
      👍️0
      jondoeuk jondoeuk 1 year ago
      Or it could end up like TRIL. ARCUS has some benefits over current CRISPR systems, manly its size, can edit the mitochondrial genome and IP is not a mess.
      👍️0
      NY1972 NY1972 1 year ago
      IECure will buy the ARCUS IP when cash is 0 in 18 months.
      👍️0
      jondoeuk jondoeuk 1 year ago
      Not the most productive use of its cash so far. The R&D Day could change that, but the market doesn't seem to think it.
      👍️0
      NY1972 NY1972 1 year ago
      this is a homeless shelter for PhDs. Cash is not spent on patients. They hired a chief people officer to cut the pie.
      👍️0
      jondoeuk jondoeuk 1 year ago
      The market did not find the recent announcement attractive https://www.businesswire.com/news/home/20230815091930/en/Precision-BioSciences-Completes-Strategic-Transaction-with-Imugene-for-Azer-Cel-in-Cancer

      I think a reverse split is a possibility, especially after the announcement couldn't move the PPS. If that happens, will likely add fuel to any downward price pressure. Management don't seem the best. Now it's do or die with the in vivo programs.
      👍️0
      rtrstock rtrstock 1 year ago
      That's what I'm afraid of, guess I'll just wait. Keep my shares.
      👍️0
      J-mak J-mak 1 year ago
      In my opinon slim very very slim
      👍️0
      rtrstock rtrstock 1 year ago
      What's the educated guess?

      What's realistically possible by October date for pps to be more than $1.00
      👍️0
      J-mak J-mak 1 year ago
      Didn't you already say that
      👍️0
      Monksdream Monksdream 1 year ago
      DTIL new 52 week low
      👍️0

      Your Recent History

      NASDAQ
      DTIL
      Precision BioSciences
      Delayed Upgrade Clock